Neuropace, Inc. Common Stock (NPCE) Stock Price

NPCEStock

$14.41+58.18%52W

Market Cap$494.61M

P/E—

PEG Ratio—

Div yield—

Beta1.88

NPCE Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-12.96%

Price vs S&P 500 (4W)5.20%

VGM Score48.71

Book Value / Share (Quarterly)$0.43

P/TBV (Annual)6.79x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)29.99%

Cash Flow / Share (Quarterly)$-0.29

Price vs S&P 500 (YTD)-19.49%

Gross Margin (TTM)78.29%

Net Profit Margin (TTM)-21.67%

EPS (TTM)$-0.65

10-Day Avg Trading Volume0.15M

EPS Excl Extra (TTM)$-0.65

Revenue Growth (5Y)19.44%

EPS (Annual)$-0.66

ROI (Annual)-27.55%

Gross Margin (Annual)77.23%

Net Profit Margin (5Y Avg)-57.82%

Cash / Share (Quarterly)$1.59

Revenue Growth QoQ (YoY)-2.02%

ROA (Last FY)-20.33%

Revenue Growth TTM (YoY)18.06%

EBITD / Share (TTM)$-0.51

ROE (5Y Avg)-159.09%

Operating Margin (TTM)-17.34%

Cash Flow / Share (Annual)$-0.34

P/B Ratio34.46x

P/B Ratio (Quarterly)30.63x

Net Income / Employee (Annual)$-102,700

EV / Revenue (TTM)5.45x

Net Interest Coverage (TTM)-3.83x

ROA (TTM)-20.64%

EPS Incl Extra (Annual)$-0.66

Current Ratio (Annual)5.28x

Quick Ratio (Quarterly)4.25x

3-Month Avg Trading Volume0.20M

52-Week Price Return58.18%

Revenue / Employee (TTM)$476,200

Tangible BV / Share (Quarterly)$0.62

P/S Ratio (Annual)4.98x

Asset Turnover (Annual)0.95x

52-Week High$19.60

Operating Margin (5Y Avg)-45.53%

EPS Excl Extra (Annual)$-0.66

CapEx CAGR (5Y)40.80%

26-Week Price Return-1.03%

Quick Ratio (Annual)4.25x

13-Week Price Return-17.14%

Total Debt / Equity (Annual)3.09x

Current Ratio (Quarterly)5.38x

Enterprise Value$542.29M

Revenue / Share Growth (5Y)11.44%

Asset Turnover (TTM)0.95x

Revenue / Employee (Annual)$478,400

Inventory Turnover (Annual)1.50x

Pretax Margin (Annual)-21.47%

Cash / Share (Annual)$1.82

3-Month Return Std Dev51.82%

Gross Margin (5Y Avg)74.03%

Net Income / Employee (TTM)$-103,200

ROE (Last FY)-112.79%

Net Interest Coverage (Annual)-3.97x

EPS Basic Excl Extra (Annual)$-0.66

Receivables Turnover (TTM)6.59x

Total Debt / Equity (Quarterly)4.08x

EPS Incl Extra (TTM)$-0.65

Receivables Turnover (Annual)7.26x

ROI (TTM)-28.12%

P/S Ratio (TTM)5.00x

Pretax Margin (5Y Avg)-57.82%

Revenue / Share (Annual)$3.06

Tangible BV / Share (Annual)$1.39

Price vs S&P 500 (52W)39.62%

Year-to-Date Return-6.67%

5-Day Price Return3.00%

EPS Normalized (Annual)$-0.66

ROA (5Y Avg)-29.58%

Net Profit Margin (Annual)-21.47%

Month-to-Date Return11.79%

Cash Flow / Share (TTM)$-1.49

EBITD / Share (Annual)$-0.51

Operating Margin (Annual)-16.84%

LT Debt / Equity (Annual)3.09x

ROI (5Y Avg)-38.63%

LT Debt / Equity (Quarterly)4.08x

EPS Basic Excl Extra (TTM)$-0.65

P/TBV (Quarterly)14.44x

P/B Ratio (Annual)27.02x

Inventory Turnover (TTM)1.43x

Pretax Margin (TTM)-21.67%

Book Value / Share (Annual)$0.57

Price vs S&P 500 (13W)-19.09%

Beta1.88x

Revenue / Share (TTM)$2.95

ROE (TTM)-120.74%

52-Week Low$8.85

vGradeD

gGradeC

mGradeB

vgmGradeC

NPCE Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q4 2025	Mar 3, 2026	-$0.15	-$0.08	+48.11%(+$0.07)
Q3 2025	Nov 4, 2025	-$0.19	-$0.11	+43.55%(+$0.08)
Q2 2025	Aug 12, 2025	-$0.22	-$0.26	-19.76%(-$0.04)

NPCE Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.21

4.20

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
NPCENeuropace, Inc. Common Stock	D	C	B	$14.41
SYKStryker Corporation	C	B	C	$330.69
MMM3M Company	C	D	C	$174.34
BSXBoston Scientific Corp.	C	B	D	$46.84
BDXBecton, Dickinson and Co.	B	D	B	$189.52
MDLNMedline Inc. Class A common stock	C	D	C	$35.28
RMDResMed Inc.	C	B	B	$240.33
DXCMDexCom, Inc.	D	B	B	$90.82
WSTWest Pharmaceutical Services, Inc.	D	C	B	$337.47
SOLVSolventum Corporation	C	C	B	$91.12
BAXBaxter International Inc.	B	D	B	$26.13
PENPenumbra, Inc.	D	C	C	$321.68
GMEDGLOBUS MEDICAL INC	B	B	C	$82.97
GKOSGlaukos Corporation	F	A	A	$179.87
PODDInsulet Corporation	C	A	C	$145.13
TFXTeleflex Incorporated	B	F	B	$139.67
STVNStevanato Group S.p.A.	D	C	C	$21.03
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$20.10
MMSIMerit Medical Systems Inc	C	B	B	$90.49
HAEHaemonetics Corporation	C	C	A	$103.96
ICUIICU Medical Inc	C	D	B	$175.10
HTFLHeartflow, Inc. Common Stock	—	A	B	$47.78
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$120.25
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$47.57
ATRCAtriCure, Inc.	D	B	B	$48.54
UFPTUFP Technologies Inc	C	B	B	$300.05
NVCRNovoCure Limited Ordinary Shares	D	C	B	$17.82
LMATLeMaitre Vascular, Inc.	C	B	C	$80.45
INSPInspire Medical Systems, Inc.	B	B	B	$61.44
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$25.64
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.43
ATECAlphatec Holdings, Inc.	D	B	C	$9.44
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.64
IARTIntegra LifeSciences Holdings	B	D	B	$16.89
AORTArtivion, Inc.	C	C	C	$26.77
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$20.83
IRMDiRadimed Corporation	D	B	C	$87.07
BVSBioventus Inc. Class A Common Stock	B	C	A	$13.84
BBNXBeta Bionics, Inc. Common Stock	D	A	B	$19.72
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.42
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.21
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.48
MDXGMiMedx Group, Inc	C	D	C	$4.50
ANGOAngioDynamics, Inc.	C	D	A	$15.85
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$23.65
BWAYBrainsway Ltd. American Depositary Shares	F	A	B	$14.30
DCTHDelcath Systems Inc	D	B	A	$16.34
CERSCerus Corp	D	C	B	$2.65
TCMDTactile Systems Technology, Inc.	B	B	C	$23.16
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$15.55
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.55

About Neuropace, Inc. Common Stock

NeuroPace develops implantable neuromodulation systems to treat epilepsy through its RNS System, which continuously monitors brain electrical activity and delivers personalized seizure prevention therapy. The company's comprehensive platform integrates implantable devices, clinical monitoring software, and patient management tools that support ongoing treatment outcomes. NeuroPace generates revenue from device sales, implantation procedures, and subscription-based patient management services.